form8k120611.htm

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): December 6, 2011
 
 
MERIDIAN BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 

 
Ohio
  
0-14902
  
31-0888197
(State or other jurisdiction of incorporation)
  
(Commission File Number)
 
  
(IRS Employer Identification No. )
 
 
3471 River Hills Drive, Cincinnati, Ohio
  
45244
  
(Address of principal executive offices)
  
(Zip Code)
  

 
Registrant’s telephone number, including area code
  
(513) 271-3700

 
 
(Former name or former address, if changed since last report.)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(b) On December 6, 2011, Gary P. Kreider notified the Board of Directors of Meridian Bioscience, Inc. (the “Company”) that he would not be accepting the nomination of the Nominating and Corporate Governance Committee for re-election to the Board at the Company’s 2012 Annual Meeting of Shareholders.



 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
MERIDIAN BIOSCIENCE, INC.
 
 
  
       
Date:  December 7, 2011
By:
/s/  Melissa A. Lueke  
    Melissa A. Lueke  
    Executive Vice President and Chief Financial Officer  
    (Principal Accounting Officer)